Our results in the glioma cell lines proficient (M059K) and defective (M059J) for DNA-PKcs suggest that tumour cells with p53 mutation, regardless of whether or not they have intact NHEJ, are likely to be fraction size insensitive. This evidence concerns the gene TP53 and central nervous system cancer.